西罗莫司预防移植物抗宿主病疗效的Meta分析(5)
[15] Armand P，Kim HT，Sainvil MM，et al.The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymph- oma：A multicentre randomized trial[J].Br J Haematol，2016，173(1)：96-104.
[16] Billingham RE.The biology of graft-versus-host reactions[J].Harvey Lect，1966，62：21-78.
[17] Storb R，Gyurkocza B，Storer BE，et al.Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation[J].J Clin Oncol，2013， 31(12)：1530-1538.
[18] Cutler C，Antin JH. Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation[J].Bone Marrow Transplant，2004;34：471-476.
[19] Choi S，Reddy P. Graft-versus-host disease[J].Panminerva Med，2010;52：11124.
[20] Labrador J，Lopez-Corral L，Lopez-Godino O，et al. Risk factors for thrombotic microang-iopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacro-limus plus MTX or sirolimus[J].Bone Marrow Transplant，2014，49(5)：684-690.
[21] Furlong T，Kiem HP，Appelbaum FR，et al.Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors[J].Biol Blood Marrow Transplant，2008，14(5)：531-537.
(收稿日期：2019-04-15), http://www.100md.com(郭璐 沈玮芸 周恒)
[16] Billingham RE.The biology of graft-versus-host reactions[J].Harvey Lect，1966，62：21-78.
[17] Storb R，Gyurkocza B，Storer BE，et al.Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation[J].J Clin Oncol，2013， 31(12)：1530-1538.
[18] Cutler C，Antin JH. Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation[J].Bone Marrow Transplant，2004;34：471-476.
[19] Choi S，Reddy P. Graft-versus-host disease[J].Panminerva Med，2010;52：11124.
[20] Labrador J，Lopez-Corral L，Lopez-Godino O，et al. Risk factors for thrombotic microang-iopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacro-limus plus MTX or sirolimus[J].Bone Marrow Transplant，2014，49(5)：684-690.
[21] Furlong T，Kiem HP，Appelbaum FR，et al.Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors[J].Biol Blood Marrow Transplant，2008，14(5)：531-537.
(收稿日期：2019-04-15), http://www.100md.com(郭璐 沈玮芸 周恒)